Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mies

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Diseases of the Colon and Rectum|December 1, 1995
Sucrase-isomaltase is an independent prognostic marker for colorectal carcinomaJ M Jessup, P T Lavin, C W Andrews, et al.
Cancer|February 6, 1998
A Phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinomaL E Morrell, Y J Lee, J Hurley, et al.
Cytometry|May 1, 1997
Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumorsM C O'Brien, S F Healy, S R Raney, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Diseases of the Colon and Rectum|December 1, 1995
Sucrase-isomaltase is an independent prognostic marker for colorectal carcinomaJ M Jessup, P T Lavin, C W Andrews, et al.
Cancer|February 6, 1998
A Phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinomaL E Morrell, Y J Lee, J Hurley, et al.
Cytometry|May 1, 1997
Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumorsM C O'Brien, S F Healy, S R Raney, et al.
Pageof 4